Clinical Trials Browser

Phase 2 × Liposarcoma × sitravatinib × Clear all

NCT02978859 2024-07-18

Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas

Phase 2 Completed

29 enrolled 11 charts

Liposarcoma, Sarcoma